Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer
Phase 1
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Interventions
- First Posted Date
- 2022-04-12
- Last Posted Date
- 2022-04-12
- Target Recruit Count
- 15
- Registration Number
- NCT05323201
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Effect of Remote Ischemic Postcondioning on Glymphatic System in Acute Stroke
Not Applicable
- Conditions
- Stroke
- Interventions
- Procedure: remote ischemic postcondioningDrug: standard therapy
- First Posted Date
- 2022-03-31
- Last Posted Date
- 2022-03-31
- Target Recruit Count
- 60
- Registration Number
- NCT05305625
Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer
Phase 2
- Conditions
- Advanced Pancreatic Cancer
- Interventions
- First Posted Date
- 2022-03-28
- Last Posted Date
- 2022-03-28
- Target Recruit Count
- 20
- Registration Number
- NCT05298020
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
A Study of Oncolytic Virus Injection (RT-01) in Combination With PD-1 Inhibitor in Patients With Advanced Solid Tumors
Phase 1
- Conditions
- Advanced Solid Tumor
- Interventions
- Biological: Oncolytic Virus Injection(RT-01)
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2022-05-09
- Target Recruit Count
- 50
- Registration Number
- NCT05228119
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer
Phase 1
Recruiting
- Conditions
- Ovarian Cancer
- Interventions
- Biological: fhB7H3.CAR-Ts
- First Posted Date
- 2022-01-27
- Last Posted Date
- 2022-01-27
- Target Recruit Count
- 15
- Registration Number
- NCT05211557
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
Phase 2
- Conditions
- SintilimabUterine Cervical Neoplasms
- Interventions
- First Posted Date
- 2021-11-03
- Last Posted Date
- 2021-12-28
- Target Recruit Count
- 20
- Registration Number
- NCT05105672
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Circulating circRNA in Acute Ischemic Stroke
Recruiting
- Conditions
- Acute Ischemic Stroke
- Interventions
- Genetic: Quantitative Real-time polymerase chain reaction
- First Posted Date
- 2021-10-28
- Last Posted Date
- 2024-08-06
- Target Recruit Count
- 500
- Registration Number
- NCT05098340
- Locations
- 🇨🇳
Department of Neurology, Xuzhou, Jiangsu, China
A Safety and Efficacy Study of Surufatinib Combination With Toripalimab in Patients With Recurrent Biliary Tract Cancer
- First Posted Date
- 2021-09-24
- Last Posted Date
- 2021-12-27
- Target Recruit Count
- 30
- Registration Number
- NCT05056116
- Locations
- 🇨🇳
The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Effect of Gene Polymorphisms on GLP-1 Receptor Agonists Response in Patients With T2DM
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Drug: GLP-1 receptor agonist
- First Posted Date
- 2021-09-08
- Last Posted Date
- 2024-11-11
- Target Recruit Count
- 338
- Registration Number
- NCT05037045
- Locations
- 🇨🇳
Department of Endocrinology, Xuzhou, Jiangsu, China
Clinical Study of CAIX-targeted CAR-T Cells in the Treatment of Advanced Renal Cell Carcinoma
Phase 1
Recruiting
- Conditions
- Immunotherapy
- Interventions
- Biological: CAR-T cell immunotherapy
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2021-07-20
- Target Recruit Count
- 20
- Registration Number
- NCT04969354
- Locations
- 🇨🇳
Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
© Copyright 2025. All Rights Reserved by MedPath